Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71:209–49.
Akhurst RJ, Hata A. Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov. 2012;11:790–811.
Google ScholarÂ
Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol cell Biol. 2019;20:69–84.
Google ScholarÂ
Yue B, Liu C, Sun H, Liu M, Song C, Cui R, et al. A positive feed-forward loop between LncRNA-CYTOR and Wnt/beta-catenin signaling promotes metastasis of colon cancer. Mol Ther : J Am Soc Gene Ther. 2018;26:1287–98.
Google ScholarÂ
Jeschke J, Collignon E, Al Wardi C, Krayem M, Bizet M, Jia Y, et al. Downregulation of the FTO m(6)A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors. Nat Cancer. 2021;2:611–28.
Google ScholarÂ
Xiao Z, Wang S, Tian Y, Lv W, Sheng H, Zhan M, et al. METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells. Cell Rep. 2023;42:112684.
Google ScholarÂ
Mendel M, Delaney K, Pandey RR, Chen KM, Wenda JM, Vagbo CB, et al. Splice site m(6)A methylation prevents binding of U2AF35 to inhibit RNA splicing. Cell. 2021;184:3125–42.e25.
Google ScholarÂ
Garbo S, D’Andrea D, Colantoni A, Fiorentino F, Mai A, Ramos A, et al. m6A modification inhibits miRNAs’ intracellular function, favoring their extracellular export for intercellular communication. Cell Rep. 2024;43:114369.
Google ScholarÂ
Xue M, Dong L, Zhang H, Li Y, Qiu K, Zhao Z, et al. METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation. J Hematol Oncol. 2024;17:7.
Google ScholarÂ
Achour C, Bhattarai DP, Groza P, Roman AC, Aguilo F. METTL3 regulates breast cancer-associated alternative splicing switches. Oncogene. 2023;42:911–25.
Google ScholarÂ
Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, et al. Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020;19:130.
Google ScholarÂ
Chen H, Gao S, Liu W, Wong CC, Wu J, Wu J, et al. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 axis and is a therapeutic target. Gastroenterology. 2021;160:1284–300.e16.
Google ScholarÂ
Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, et al. m(6)A-dependent glycolysis enhances colorectal cancer progression. Mol cancer. 2020;19:72.
Google ScholarÂ
Tian F, Huang J, Fan W, Li X, Zhan Y, Zhu K, et al. m(6)A-modified EHD1 controls PD-L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma. Cancer Commun. 2025;45:1285–308.
Google ScholarÂ
Li S, Zhou J, Wang S, Yang Q, Nie S, Ji C, et al. N(6)-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis. Cancer Commun. 2025;45:941–65.
Google ScholarÂ
Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol cancer. 2019;18:142.
Google ScholarÂ
Yue B, Cai D, Liu C, Fang C, Yan D. Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer. Mol Ther : J Am Soc Gene Ther. 2016;24:2064–77.
Google ScholarÂ
Yue B, Cui R, Zheng R, Jin W, Song C, Bao T, et al. Essential role of ALKBH5-mediated RNA demethylation modification in bile acid-induced gastric intestinal metaplasia. Mol Ther Nucleic acids. 2021;26:458–72.
Google ScholarÂ
Cao LL, Lu H, Soutto M, Bhat N, Chen Z, Peng D, et al. Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-gamma signalling. Gut. 2023;72:2038–50.
Google ScholarÂ
Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.
Google ScholarÂ
Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14:6523.
Google ScholarÂ
Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74:640–50.
Google ScholarÂ
Yang X, Bai Q, Chen W, Liang J, Wang F, Gu W, et al. m(6) A-dependent modulation via IGF2BP3/MCM5/notch axis promotes partial EMT and LUAD metastasis. Adv Sci. 2023;10:e2206744.
Google ScholarÂ
Chen M, Yang Y, Hu G, Peng Z, Wen W. The promoting effect of the POU3F2/METTL16/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma. Ann Hepatol. 2025;30:101776.
Google ScholarÂ
Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, et al. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer. Cancer Res. 2023;83:2187–207.
Google ScholarÂ
Yadav P, Subbarayalu P, Medina D, Nirzhor S, Timilsina S, Rajamanickam S, et al. M6A RNA methylation regulates histone ubiquitination to support cancer growth and progression. Cancer Res. 2022;82:1872–89.
Google ScholarÂ
Liu Q, Pang J, Wang LA, Huang Z, Xu J, Yang X, et al. Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2. J Pathol. 2021;253:106–18.
Google ScholarÂ
Hannezo E, Heisenberg CP. Mechanochemical feedback loops in development and disease. Cell. 2019;178:12–25.
Google ScholarÂ
Zhu Y, Huang C, Zhang C, Zhou Y, Zhao E, Zhang Y, et al. LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation. Nat Commun. 2023;14:8141.
Google ScholarÂ
Sun Y, He J, Shi DB, Zhang H, Chen X, Xing AY, et al. Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma. J Cancer Res Clin Oncol. 2021;147:105–15.
Google ScholarÂ
Simoes-Correia J, Figueiredo J, Oliveira C, van Hengel J, Seruca R, van Roy F, et al. Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Hum Mol Genet. 2008;17:3566–76.
Google ScholarÂ
Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol cancer. 2019;18:64.
Google ScholarÂ
Zhang C, Yu Z, Yang S, Liu Y, Song J, Mao J, et al. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner. Mol Cancer. 2024;23:33.
Google ScholarÂ
Hao T, Xu J, Fang S, Jiang J, Chen X, Wu W, et al. Overexpression of ZNF460 predicts worse survival and promotes metastasis through JAK2/STAT3 signaling pathway in patient with colon cancer. J Cancer. 2021;12:3198–208.
Google ScholarÂ
An L, Liu Y. ZNF460 mediates epithelial-mesenchymal transition to promote gastric cancer progression by transactivating APOC1 expression. Exp cell Res. 2023;422:113452.
Google ScholarÂ
Li L, Liu X, He L, Yang J, Pei F, Li W, et al. ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin. Nat Commun. 2017;8:691.
Google ScholarÂ
Li N, Li Y, Lv J, Zheng X, Wen H, Shen H, et al. ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes. Mol cell. 2016;63:470–84.
Google ScholarÂ
Mi W, Zhang Y, Lyu J, Wang X, Tong Q, Peng D, et al. The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation. Nat Commun. 2018;9:3759.
Google ScholarÂ
Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol cancer. 2020;19:106.
Google ScholarÂ
Wen T, Zhang X, Gao Y, Tian H, Fan L, Yang P. SOX4-BMI1 axis promotes non-small cell lung cancer progression and facilitates angiogenesis by suppressing ZNF24. Cell Death Dis. 2024;15:698.
Google ScholarÂ
Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A, et al. Integrin alphavbeta6-TGFbeta-SOX4 pathway drives immune evasion in triple-negative breast cancer. Cancer cell. 2021;39:54–67.e9.
Google ScholarÂ
Tan XY, Li YT, Li HH, Ma LX, Zeng CM, Zhang TT, et al. WNT2-SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer. Oncogene. 2023;42:3062–74.
Google ScholarÂ
Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23:768–83.
Google ScholarÂ
Zhang Y, Sun Z, Jia J, Du T, Zhang N, Tang Y, et al. Overview of histone modification. Adv Exp Med Biol. 2021;1283:1–16.
Google ScholarÂ
Fan T, Xie J, Huang G, Li L, Zeng X, Tao Q. PHF8/KDM7B: a versatile histone demethylase and epigenetic modifier in nervous system disease and cancers. Epigenomes. 2024;8:36.
Dai J, Lu X, Zhang C, Qu T, Li W, Su J, et al. NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer. Mol Cancer. 2025;24:79.
Google ScholarÂ
Hu Z, Sui Q, Jin X, Shan G, Huang Y, Yi Y, et al. IL6-STAT3-C/EBPbeta-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma. J Exp Clin Cancer Res : CR. 2024;43:63.
Google ScholarÂ
